These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 21521861

  • 1. Symptom reporting compared with audiometry for the detection of cochleotoxicity in patients on long-term aminoglycoside therapy.
    Palmay L, Walker SA, Walker SE, Simor AE.
    Ann Pharmacother; 2011 May; 45(5):590-5. PubMed ID: 21521861
    [Abstract] [Full Text] [Related]

  • 2. Comparative auditory toxicity of aminoglycoside antibiotics in leukopenic patients.
    Bender JF, Fortner CL, Schimpff SC, Grove WR, Hahn DM, Love LJ, Wiernik PH.
    Am J Hosp Pharm; 1979 Aug; 36(8):1083-7. PubMed ID: 484567
    [Abstract] [Full Text] [Related]

  • 3. [Is it possible to recognize aminoglycoside ototoxicity early using evoked potentials?].
    Pechère JC, Bernard P.
    Ann Med Interne (Paris); 1980 Aug; 131(6):329-30. PubMed ID: 7469233
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of utilising patient self-report of auditory complaints to monitor aminoglycoside ototoxicity.
    Ramma LD, Ibekwe TS.
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):283. PubMed ID: 22236938
    [No Abstract] [Full Text] [Related]

  • 6. Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: selected case studies.
    Fausti SA, Rappaport BZ, Schechter MA, Frey RH, Ward TT, Brummett RE.
    Am J Otolaryngol; 1984 Feb; 5(3):177-82. PubMed ID: 6742338
    [Abstract] [Full Text] [Related]

  • 7. Developmental ototoxicity.
    Henley CM, Rybak LP.
    Otolaryngol Clin North Am; 1993 Oct; 26(5):857-71. PubMed ID: 8233494
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aminoglycoside cochlear ototoxicity.
    Matz GJ.
    Otolaryngol Clin North Am; 1993 Oct; 26(5):705-12. PubMed ID: 8233484
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [New data on the ototoxicity of aminoglycoside antibiotics].
    Federspil P.
    Adv Clin Pharmacol; 1978 Oct; 15():45-68. PubMed ID: 354351
    [No Abstract] [Full Text] [Related]

  • 13. Aminoglycosides: assessing the potential for nephrotoxicity.
    Wilson SE.
    Surg Gynecol Obstet; 1990 Oct; 171 Suppl():24-30. PubMed ID: 2244292
    [Abstract] [Full Text] [Related]

  • 14. Negative hearing effects of a single course of IV aminoglycoside therapy in cystic fibrosis patients.
    Gleser MA, Zettner EM.
    Int J Audiol; 2018 Dec; 57(12):917-924. PubMed ID: 30382794
    [Abstract] [Full Text] [Related]

  • 15. [Early diagnosis, prevention and treatment of hearing disorders occurring following the intake of antibiotics].
    Giul'khasian AA.
    Zh Ushn Nos Gorl Bolezn; 1973 Dec; 33(6):8-12. PubMed ID: 4786993
    [No Abstract] [Full Text] [Related]

  • 16. [Vestibulometry in prognosis of lesions of the organ of hearing after administration of aminoglycoside antibiotics].
    Bazarov VG, Mishchanchuk NS.
    Zh Ushn Nos Gorl Bolezn; 1978 Dec; (6):21-7. PubMed ID: 216180
    [No Abstract] [Full Text] [Related]

  • 17. Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis.
    de Jager P, van Altena R.
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):622-7. PubMed ID: 12102302
    [Abstract] [Full Text] [Related]

  • 18. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.
    Al-Aloul M, Miller H, Alapati S, Stockton PA, Ledson MJ, Walshaw MJ.
    Pediatr Pulmonol; 2005 Jan; 39(1):15-20. PubMed ID: 15521084
    [Abstract] [Full Text] [Related]

  • 19. Biochemistry and pharmacology of aminoglycoside-induced hearing loss.
    Schacht J.
    Acta Physiol Pharmacol Ther Latinoam; 1999 Jan; 49(4):251-6. PubMed ID: 10797868
    [Abstract] [Full Text] [Related]

  • 20. Factors associated with sensorineural hearing loss among survivors of extracorporeal membrane oxygenation therapy.
    Fligor BJ, Neault MW, Mullen CH, Feldman HA, Jones DT.
    Pediatrics; 2005 Jun; 115(6):1519-28. PubMed ID: 15930212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.